Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384300 | SCV001583752 | pathogenic | not provided | 2021-06-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant has been observed in individual(s) with clinical features of Usher syndrome (PMID: 30073356). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ile5067Serfs*23) in the USH2A gene. It is expected to result in an absent or disrupted protein product. |
Natera, |
RCV001831387 | SCV002088197 | pathogenic | Usher syndrome type 2A | 2020-07-14 | no assertion criteria provided | clinical testing |